BiTE® TECHNOLOGY: DESIGNED TO ENGAGE T CELLS TO FIGHT CANCER

Despite recent advances in immuno-oncology, not enough patients benefit from current treatments and additional options are needed to address both hematologic malignancies and solid tumors.

SHARE